Palisade Bio to Participate in the Virtual Investor Lunch Break Event

Rhea-AI Summary

Palisade Bio, Inc. (PALI) to present at the Virtual Investor Lunch Break event, featuring an overview by CEO J.D. Finley and CMO Dr. Mitch Jones. The live webcast on April 16, 2024, will focus on the company's business outlook and opportunities in autoimmune, inflammatory, and fibrotic diseases.

– Live webcast with members of Palisade Bio management on Tuesday, April 16^th at 12:00 PM ET

Carlsbad, CA, April 11, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that it will present at the Virtual Investor Lunch Break Featuring Palisade Bio event on Tuesday, April 16, 2024 at 12:00 PM ET.

As part of the event, J.D. Finley, Chief Executive Officer and Dr. Mitch Jones, Chief Medical Officer of Palisade Bio, will provide a corporate overview, business outlook, and discuss the Palisade Bio opportunity.

A live video webcast of the presentation will be available on the Events page of the Investors section of the Company’s website (www.palisadebio.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.

About Palisade Bio 
Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.

Investor Relations Contact
JTC Team, LLC
Jenene Thomas
833-475-8247
PALI@jtcir.com

When is Palisade Bio presenting at the Virtual Investor Lunch Break event?

Palisade Bio is presenting at the Virtual Investor Lunch Break event on Tuesday, April 16, 2024, at 12:00 PM ET.

Who will provide an overview at the event?

CEO J.D. Finley and CMO Dr. Mitch Jones will provide a corporate overview at the event.

What diseases does Palisade Bio focus on?

Palisade Bio focuses on developing therapeutics for patients with autoimmune, inflammatory, and fibrotic diseases.

Where can the live webcast be viewed?

The live video webcast will be available on the Events page of the Investors section on Palisade Bio's website.

How long will the webcast replay be accessible?

The webcast replay will be accessible for 90 days following the live presentation.